Visual Snow Syndrome Improves With Modulation of Resting-State Functional MRI Connectivity After Mindfulness-Based Cognitive Therapy: An Open-Label Feasibility Study.
Sui H Wong, Giuseppe Pontillo, Baris Kanber, Ferran Prados, Janet Wingrove, Marios Yiannakas, Indran Davagnanam, Claudia A M Gandini Wheeler-Kingshott, Ahmed T Toosy
Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society March 1, 2024 DOI: 10.1097/wno.0000000000002013 (opens in new tab) via PubMed
Summary
AI-generated from the abstractAn 8-week mindfulness-based cognitive therapy program customized for visual symptoms (MBCT-vision) was tested in an open-label feasibility study with 21 adults who have visual snow syndrome. Symptom severity and impact on daily life improved at Week 9 and Week 20 compared with baseline, and wellbeing and distress scores also improved. Brain imaging in a subset of participants showed changes in functional connectivity of visual networks from baseline to Week 20. The therapy appeared feasible and associated with symptom improvement and modulation of visual network connectivity.
Study at a glance
| Characteristics | Open-label feasibility study Peer reviewed |
|---|---|
| Sample size | 21 |
| Population | Adults with visual snow syndrome |
| Duration | 8-week intervention, follow-up at Week 9 and Week 20 |
| Key finding | MBCT-vision was associated with reduced symptom severity and impact on daily life, and with changes in functional connectivity of visual networks. |
Abstract
Visual snow syndrome (VSS) is associated with functional connectivity (FC) dysregulation of visual networks (VNs). We hypothesized that mindfulness-based cognitive therapy, customized for visual symptoms (MBCT-vision), can treat VSS and modulate dysfunctional VNs. An open-label feasibility study for an 8-week MBCT-vision treatment program was conducted. Primary (symptom severity; impact on daily life) and secondary (WHO-5; CORE-10) outcomes at Week 9 and Week 20 were compared with baseline. Secondary MRI outcomes in a subcohort compared resting-state functional and diffusion MRI between baseline and Week 20. Twenty-one participants (14 male participants, median 30 years, range 22-56 years) recruited from January 2020 to October 2021. Two (9.5%) dropped out. Self-rated symptom severity (0-10) improved: baseline (median [interquartile range (IQR)] 7 [6-8]) vs Week 9 (5.5 [3-7], P = 0.015) and Week 20 (4 [3-6], P < 0.001), respectively. Self-rated impact of symptoms on daily life (0-10) improved: baseline (6 [5-8]) vs Week 9 (4 [2-5], P = 0.003) and Week 20 (2 [1-3], P < 0.001), respectively. WHO-5 Wellbeing (0-100) improved: baseline (median [IQR] 52 [36-56]) vs Week 9 (median 64 [47-80], P = 0.001) and Week 20 (68 [48-76], P < 0.001), respectively. CORE-10 Distress (0-40) improved: baseline (15 [12-20]) vs Week 9 (12.5 [11-16.5], P = 0.003) and Week 20 (11 [10-14], P = 0.003), respectively. Within-subject fMRI analysis found reductions between baseline and Week 20, within VN-related FC in the i) left lateral occipital cortex (size = 82 mL, familywise error [FWE]-corrected P value = 0.006) and ii) left cerebellar lobules VIIb/VIII (size = 65 mL, FWE-corrected P value = 0.02), and increases within VN-related FC in the precuneus/posterior cingulate cortex (size = 69 mL, cluster-level FWE-corrected P value = 0.02). MBCT-vision was a feasible treatment for VSS, improved symptoms and modulated FC of VNs. This study also showed proof-of-concept for intensive mindfulness interventions in the treatment of neurological conditions.